Caroline M. Loewy - 09 Sep 2023 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Caroline M. Loewy
Issuer symbol
EFTR on OTC
Transactions as of
09 Sep 2023
Net transactions value
$0
Form type
4
Filing time
11 Sep 2023, 19:38:35 UTC
Previous filing
19 May 2023
Next filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 09 Sep 2023 Common Stock 40,000 $0.6460 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on September 9, 2023, subject to the Reporting Person's continued service with the Issuer through each vesting date.